249 related articles for article (PubMed ID: 31571090)
21. Sebaceoma of the eyelid: a rare entity.
Mittal R; Tripathy D
Can J Ophthalmol; 2014 Jun; 49(3):e78-80. PubMed ID: 24862791
[No Abstract] [Full Text] [Related]
22. Expression of retinoic acid-binding proteins and retinoic acid receptors in sebaceous cell carcinoma of the eyelids.
Tsai YJ; Wu SY; Huang HY; Ma DH; Wang NK; Hsiao CH; Cheng CY; Yeh LK
BMC Ophthalmol; 2015 Oct; 15():142. PubMed ID: 26503156
[TBL] [Abstract][Full Text] [Related]
23. Immunohistochemical evaluation of stress-responsive protein sestrin2 and its correlation with p53 mutational status in eyelid sebaceous gland carcinoma.
Jayaraj P; Sen S; Rangarajan S; Ray N; Vasu K; Singh VK; Phartyal R; Yadav S; Verma A
Br J Ophthalmol; 2018 Jun; 102(6):848-854. PubMed ID: 29478030
[TBL] [Abstract][Full Text] [Related]
24. Prognostic significance of immune checkpoints in the tumour-stromal microenvironment of sebaceous gland carcinoma.
Singh L; Singh MK; Rizvi MA; Pushker N; Bakhshi S; Sen S; Kashyap S
Br J Ophthalmol; 2021 Jan; 105(1):48-56. PubMed ID: 32277010
[TBL] [Abstract][Full Text] [Related]
25. Sebaceous carcinoma. Tumor progression through mutational inactivation of p53.
Gonzalez-Fernandez F; Kaltreider SA; Patnaik BD; Retief JD; Bao Y; Newman S; Stoler MH; Levine PA
Ophthalmology; 1998 Mar; 105(3):497-506. PubMed ID: 9499782
[TBL] [Abstract][Full Text] [Related]
26. Expression of alpha-crystallins in human sebaceous carcinoma of the eyelid.
Rigas PK; Kase S; Rao NA
Eur J Ophthalmol; 2009; 19(5):702-7. PubMed ID: 19787585
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of PD-L1 and PD-1 expression in aggressive eyelid sebaceous gland carcinoma and its clinical significance.
Jayaraj P; Sen S
Indian J Ophthalmol; 2019 Dec; 67(12):1983-1987. PubMed ID: 31755433
[TBL] [Abstract][Full Text] [Related]
28. Loss of fragile histidine triad (FHIT) expression and microsatellite instability in periocular sebaceous gland carcinoma in patients with Muir-Torre syndrome.
Holbach LM; von Moller A; Decker C; Jünemann AG; Rummelt-Hofmann C; Ballhausen WG
Am J Ophthalmol; 2002 Jul; 134(1):147-8. PubMed ID: 12095833
[TBL] [Abstract][Full Text] [Related]
29. miRNA-200c and miRNA-141 as potential prognostic biomarkers and regulators of epithelial-mesenchymal transition in eyelid sebaceous gland carcinoma.
Bhardwaj M; Sen S; Chosdol K; Sharma A; Pushker N; Kashyap S; Bakhshi S; Bajaj MS
Br J Ophthalmol; 2017 Apr; 101(4):536-542. PubMed ID: 28119291
[TBL] [Abstract][Full Text] [Related]
30. Retinoid receptor subtypes in sebaceous cell carcinoma of the eyelid.
Chakravarti N; Saadati HG; El-Naggar AK; Lotan R; Diba RE; Esmaeli B
Ophthalmic Plast Reconstr Surg; 2005 Jul; 21(4):292-7. PubMed ID: 16052143
[TBL] [Abstract][Full Text] [Related]
31. Sebaceoma of the eyelid.
Yonekawa Y; Jakobiec FA; Zakka FR; Fay A
Ophthalmology; 2012 Dec; 119(12):2645.e1-4. PubMed ID: 23207023
[No Abstract] [Full Text] [Related]
32. Prevalence of human papillomavirus in eyelid carcinoma among Koreans: a clinicopathological study.
Yang MK; Kim N; Choung H; Kim JE; Khwarg SI
BMC Ophthalmol; 2023 Sep; 23(1):390. PubMed ID: 37752463
[TBL] [Abstract][Full Text] [Related]
33. Establishment and Characterization of a TP53-Mutated Eyelid Sebaceous Carcinoma Cell Line.
Gu X; Huang Z; Chen J; Luo Y; Ge S; Jia R; Song X; Chai P; Xu S; Fan X
Invest Ophthalmol Vis Sci; 2023 Dec; 64(15):16. PubMed ID: 38095907
[TBL] [Abstract][Full Text] [Related]
34. Merkel cell carcinoma co-existent with sebaceous carcinoma of the eyelid.
Tanahashi J; Kashima K; Daa T; Yada N; Fujiwara S; Yokoyama S
J Cutan Pathol; 2009 Sep; 36(9):983-6. PubMed ID: 19017040
[TBL] [Abstract][Full Text] [Related]
35. Distinct pathways in the pathogenesis of sebaceous carcinomas implicated by differentially expressed microRNAs.
Tetzlaff MT; Curry JL; Yin V; Pattanaprichakul P; Manonukul J; Uiprasertkul M; Manyam GC; Wani KM; Aldape K; Zhang L; Prieto VG; Esmaeli B
JAMA Ophthalmol; 2015 Oct; 133(10):1109-16. PubMed ID: 26203913
[TBL] [Abstract][Full Text] [Related]
36. Loss of p21(WAF1) compartmentalisation in sebaceous carcinoma compared with sebaceous hyperplasia and sebaceous adenoma.
McBride SR; Leonard N; Reynolds NJ
J Clin Pathol; 2002 Oct; 55(10):763-6. PubMed ID: 12354803
[TBL] [Abstract][Full Text] [Related]
37. Sebaceous gland tumors of the eyelids and conjunctiva in the Muir-Torre syndrome: a clinicopathologic study of five cases and literature review.
Rishi K; Font RL
Ophthalmic Plast Reconstr Surg; 2004 Jan; 20(1):31-6. PubMed ID: 14752307
[TBL] [Abstract][Full Text] [Related]
38. Eyelid sebaceous gland carcinoma, validation of AJCC 8th edition T staging- a retrospective study from North India.
Sen S; Bhardwaj M; Jayaraj P; Bakhshi S; Pushker N; Kashyap S; Bajaj MS; Khandpur S
Acta Ophthalmol; 2023 Feb; 101(1):49-56. PubMed ID: 35751173
[TBL] [Abstract][Full Text] [Related]
39. Recurrent sebaceous gland carcinoma of eyelid previously diagnosed as basal cell carcinoma: case report.
Kan LW; Leu YS; Tzen CY; Wu CH
Am J Otolaryngol; 2011; 32(6):620-3. PubMed ID: 21168242
[TBL] [Abstract][Full Text] [Related]
40. Eyelid sebaceous carcinoma: clinicopathologic and multiparametric immunohistochemical analysis that includes adipophilin.
Jakobiec FA; Mendoza PR
Am J Ophthalmol; 2014 Jan; 157(1):186-208.e2. PubMed ID: 24112633
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
